Skip to Navigation Skip to Content
Learn about the 3 convenient formulations of Zomig
Zomig is indicated for the acute treatment of migraine with or without aura in adults. Only use ZOMIG if a clear diagnosis of migraine has been established. If a patient has no response to ZOMIG treatment for the first migraine attack, reconsider the diagnosis of migraine before ZOMIG is administered to treat any subsequent attacks. ZOMIG is not indicated for the prevention of migraine attacks. Safety and effectiveness of ZOMIG have not been established for cluster headache.
Please click here for full Prescribing Information for Zomig Tablets and Zomig-ZMT Orally Disintegrating Tablets.
Please click here for full Prescribing Information for Zomig Nasal Spray.
Important Safety Information
US Corporate Site
Home3 Formulations of ZomigProfessional Resources
This product information is intended for US health care professionals only.
Zomig and Zomig-ZMT are registered trademarks of the AstraZeneca group of companies.
Copyright © 2012 Impax Pharmaceuticals, A Division of Impax Laboratories, Inc.
All rights reserved. 2199503 Last updated 11/12